Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Fosaprepitant for PONV in Laparoscopic Cholecystectomy
NCT03586817Phase 4Unknown
- Sponsor
- Hospital Federal de Bonsucesso
- Start
- Mar 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palonosetron, fosaprepitant in postoperative nausea and vomiting (PONV), sponsored by Hospital Federal de Bonsucesso. Status: unknown.
02
Drugs
palonosetronfosaprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03586817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586817.